Next Article in Journal / Special Issue
Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review
Previous Article in Journal / Special Issue
Inside the Cell: Integrins as New Governors of Nuclear Alterations?
Article Menu
Issue 7 (July) cover image

Export Article

Open AccessFeature PaperReview
Cancers 2017, 9(7), 84; doi:10.3390/cancers9070084

Integrin αvβ3 Signaling in Tumor-Induced Bone Disease

Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN 37212, USA
Vanderbilt Center for Bone Biology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
Department of Cancer Biology, Vanderbilt University, Nashville, TN 37232, USA
Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37235, USA
Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
Author to whom correspondence should be addressed.
Received: 15 June 2017 / Revised: 5 July 2017 / Accepted: 5 July 2017 / Published: 8 July 2017
(This article belongs to the Special Issue Integrins in Cancer)
View Full-Text   |   Download PDF [603 KB, uploaded 8 July 2017]   |  


Tumor-induced bone disease is common among patients with advanced solid cancers, especially those with breast, prostate, and lung malignancies. The tendency of these cancers to metastasize to bone and induce bone destruction is, in part, due to alterations in integrin expression and signaling. Substantial evidence from preclinical studies shows that increased expression of integrin αvβ3 in tumor cells promotes the metastatic and bone-invasive phenotype. Integrin αvβ3 mediates cell adhesion to several extracellular matrix proteins in the bone microenvironment which is necessary for tumor cell colonization as well as the transmission of mechanical signals for tumor progression. This review will discuss the αvβ3 integrin receptor in the context of tumor-induced bone disease. Specifically, the focus will be the role of αvβ3 in modulating cancer metastasis to bone and tumor cell response to the bone microenvironment, including downstream signaling pathways that contribute to tumor-induced osteolysis. A better understanding of integrin dysregulation in cancer is critical to developing new therapeutics for the prevention and treatment of bone metastases. View Full-Text
Keywords: integrins; bone tumors; bone metastasis; tumor microenvironment integrins; bone tumors; bone metastasis; tumor microenvironment

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Kwakwa, K.A.; Sterling, J.A. Integrin αvβ3 Signaling in Tumor-Induced Bone Disease. Cancers 2017, 9, 84.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top